Navigation Links
Lumalier Partners with Philips Healthcare to Provide Tru-D Solution for Reduction of Environmental Pathogens in Healthcare Facilities
Date:7/14/2011

MEMPHIS, Tenn., July 14, 2011 /PRNewswire/ -- Lumalier Corporation announces an agreement with Philips Healthcare to address the growing problem of microbial contamination in hospitals. The distribution agreement was announced at the annual conference of the Association for Professionals in Infection Control and Hospital Epidemiology (APIC), where representatives from Philips Healthcare joined Lumalier consultants to showcase the Tru-D total-room ultraviolet (UV) disinfector.

Tru-D is an automated, no-touch, portable UV device that helps control pathogens known to contaminate environmental surfaces. Thorough environmental cleaning is at the forefront at a time when healthcare-acquired infections (HAIs) are the most common complication of hospital care and one of the top ten leading causes of death in the United States.

"Manual cleaning can be fraught with human error -- especially in hard-to-reach places," says Jeffrey Stephens, MD, professor of medicine and infectious diseases at Mercer University School of Medicine, Medical Center of Central Georgia. "The Tru-D Sensor360™ technology measures the reflected dose of UV light to reduce pathogens on visible surfaces, in primary shadows, behind and below bed rails, trays, doorknobs, IV poles and portable equipment." Scientific data provided by published, peer-reviewed studies indicate that no UV Room Disinfection System other than Tru-D can substantiate these high-level disinfection claims (1,2,3).

Environmental cleaning was the focus of several presentations at the APIC conference. Dr. William Rutala, PhD, MPH, Professor of Infectious Diseases at the University of North Carolina's School of Medicine, reviewed issues associated with environmental hygiene and room decontamination and presented Tru-D as an emerging automated disinfection technology.

In a separate presentation, Ann Marie Pettis, RN, BSN, CIC, Director of Infection Prevention at University of Rochester Medical Center, described how innovative Tru-D technology is being used to significantly reduce Clostridium difficile spores in clinical patient care areas, nursing units and operating rooms.

Studies demonstrate that only 48 percent of hospital environmental surfaces are cleaned at terminal room cleaning. "Tru-D is a simple option to help eliminate pathogens," says William Carroll Thompson, vice president of service for patient monitoring at Philips Healthcare. "As a company dedicated to simplifying healthcare, we are very pleased to bring this innovative solution to our customers and to their patients."

To review published, peer-reviewed Tru-D studies for the environmental elimination of MRSA, Acinetobacter, VRE, C.diff, and other infectious pathogens, visit http://Tru-D.net. For additional information on Tru-D technology or to request an on-site demonstration, please call 800-774-5799 or contact Chuck Dunn @ ChuckDunn@lumalier.com.

1. Nancy Nerandzic; Curtis Donskey, MD, 'Evaluation of an Automated Ultraviolet Radiation Device for Decontamination of Healthcare-Associated pathogens in Hospital Rooms and on Portable Medical Equipment', BMS Infections Diseases 2010, 10:197.

2. William Rutala, PhD, MPH; Maria Gergen MT (ASCP); David J Weber, MD, MPH, 'Room Decontamination with UV Radiation', Infection Control and Hospital Epidemiology, October 2010, Vol 31, No. 10.

3. Vipin K. Rastogi, PhD; Lalena Wallace, MS; Lisa S. Smith, MS, 'Disinfection of Acinetobacter baumannii-Contaminated Surfaces Relevant to Medical Treatment Facilities with Ultraviolet C Light', Military Medicine 2007, 172, 11:1166.

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE Lumalier Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
5. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
6. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
7. UNICEF Partners With Causes on Facebook to Launch Charity Gift Feature
8. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
9. iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product
10. Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
11. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... Dec 9, 2016 Research and Markets ... 2016-2020" report to their offering. ... The report forecasts the global optical transceiver ... 2016-2020. The report covers the present scenario and ... To calculate the market size, the report considers the revenue generated ...
(Date:12/9/2016)... Dec. 9, 2016  Harmar Mobility, LLC announced today that Steven ... of the Board of Directors. Photo - http://photos.prnewswire.com/prnh/20161209/447552 ... ... Mr. Dawson,s executive career includes ... across a variety of industries. He brings to the company deep ...
(Date:12/9/2016)... Dec. 9, 2016 aTyr Pharma, Inc. (Nasdaq: ... of Physiocrine-based therapeutics to address severe, rare diseases, today announced that ... BMO Prescriptions for Success Healthcare Conference at the InterContinental Barclay Hotel ... 14, 2016, at 4:20 p.m. ET. About aTyr ... aTyr ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, ... announced today that a new solution for Emergency Departments (ED) has been added ... space in Emergency Department examination rooms, and with a simplified pallet of information ...
(Date:12/8/2016)... ... 08, 2016 , ... After enjoying record-breaking attendance at its ... its 33rd Annual Issues & Research Conference, March 2-3, 2017, at the ... conference is “Persistent Challenges and New Opportunities: Using Research to Accelerate the Dialogue." ...
(Date:12/8/2016)... Plainsboro, NJ (PRWEB) , ... December 08, 2016 , ... ... patients, cancer centers and advocacy groups, has aligned with Upstage Lung Cancer in efforts ... In making the announcement, Michael J. Hennessy, Jr said, “CURE Media Group is honored ...
(Date:12/8/2016)... ... December 08, 2016 , ... Launching of ... Unified Instance Manager architecture, meeting the needs of multichannel growth and doubling ... unattended auto-dialing system without agents, Presence Robodialer, provides greater operational capacity, administrative ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are encouraged ... in mind, SIGVARIS has created a new line of anti-embolism stockings to help ... provide the benefits of graduated compression when transitioning from recovery to early rehabilitation. ...
Breaking Medicine News(10 mins):